Why Less Frequent Dosing May Matter With Long-Acting IL-13 Biologics

(MedPage Today) -- During the recent American Academy of Dermatology (AAD) annual meeting, MedPage Today brought together three expert leaders for a virtual roundtable discussion on atopic dermatitis: Moderator Peter A. Lio, MD, of Northwestern...
Source
MedPage Today
Opens original article in a new tab



